• About Us  • Services  • Studies  • Coding Manual  • FAQs  • History  • Minnesota Code(pdf)  • MN ECG Home

Studies Using the MN ECG

The Minnesota Central ECG Laboratory was, or is, the Core ECG Center of numerous clinical trials and epidemiologic studies.

These trials and studies have ranged from international multicenter complex efforts (40,000 plus participants) to simple local trials.

National/ International

• ALLHAT Atrial Fibrillation Study
• the Anemia Study
• Anti-Lipid Lowering Heart Attack Trial (ALLHAT)
• Australian National Blood Pressure Study (ANBPS)
• Atheroclerosis Risk in Communities Study (ARIC)
• Beta Blocker Heart Attack Trial (BHAT)
• Boston Health Care Project (BHC)
• Budapest WHO Test ECG Coding
• Cardiovascular Disease among Seattles Japanese (NDP)
• Center for Disease Translation Study (CDT)
• the China 1990 Study
• Community Diabetes Project (RTI)
• Comparison of ECG Algoritms for Ischemic Endpoints Study
• Coronary Artery Risk Development in Young Adults (CARDIA)
• Coronary Drug Project (CDP)
• Coronary Risk in Seniors Program (CRISP)
• Chicago Western Electric (CHE)
• CVD Risk Factors and Brain Morphology in NHLBI Twins (TWINS)
• Diabetes Control and Complications Trial (DCCT)
• Diabetes Prevention in Yupik Eskimos (ESKIMO)
• Early Treatment of Diabetic Retinopathy Study (ETDRS)
• Enhancing Recovery in Coronary Heart Disease (ENRICH)
• Epidemiology of Diabetes Intervention and Complications (EDIC)
• Evans County and Charleston Heart Studies
• Gaurdian ECG Minnesota Code Analysis (GAURDIAN)
• HDL Intervention Trial (HIT)
• Healthy Heart Study (HHS)
• Heart Rate Variability and Survival after MI Study
• Hip Fracture Study (HIP)
• Hypertension Control Program (HCP)
• Hypertension Detection and Follow-up Program (HDFP)
• Indian Heart Study
• Inter-Tribal Heart Project (ITHP)
• the Kronhort Study
• Lipid Researech Centers Study (LIPID)
• Lorsartan Intervention for Endpoint Reduction in Hypertension Project (LIFE)
• Lorsartan NIDDM Endpoint Study
• Lorsartan Post MI Study
• Meharry Cohort Study (MCS)
• Mexico City Diabetes Study
• Miami Senior Health Trial (MSHT)
• Multiple Risk Factor Intervention Trial (MRFIT)
• Munich Transit Worker Cardiovascular Risk Factor Intervention Study (GERMANY)
• National Health and Nutrition Examination Study (NHANES)
• National Hypertension Study (NHP)
• Nicotine Patch Study (NPS)
• Normative Aging Study (NRM)
• New York Bridge and Tunnel Workers Study (BNT)
• New York State MI Validation Study
• NIDDM Primary Prevention Trial
• Occupational Exposure Study
• Otsego-Schoharie Healthy Heart Program (OSH)
• Pawtucket Heart Health Program
• Pfizer/Parke-Davis TNT Program (GDXI)
• Poland Study- Warsaw and Cracow
• the Precursors Study
• Prevention of High Blood Pressure in Children Study (PHBPC)
• the Reaven Study
• Renal and Cardiovascular Disease in Navajo Indians with Type II Diabetes (NAVAJO)
• Renal Protective Effects of Lorsartan Study
• San Antonio Heart Study
• San Luis Valley Diabetes Study (SLV)
• Scandinavian Simvastatin Survival Study (4S)
• Seven Countries Study, 9 Hypertension Control Program (HCP)
• the SHEPII Study
• Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK)
• Sodium-Potassium Study in Children (NAKS)
• Solomon Island ECG Study
• the Southeastern Kidney Council Study
• Spinal Cord Injury and Carsiovascular Disease Study
• Stanford Heart Disease Prevention Program (STANFORD)
• Strong Heart Study (SHS)
• Systolic Hypertension in Elderly Program (SHEP)
• Tamoxifen and Risk of Subsequent Thrombembolic Disease (TKP)
• Tiawan- case control study of myocardial ischemia and injury (TIAWAN)
• Treatment of Mild Hypertension Study (TOMHS)
• the Trichlorotrifluorethane Study
• VA Collaborative Study on Insulin Dependent Diabetes
• VA Cooperative 344 Study
• Vascular Disease in Women Study

Local/ Regional

• Mayo Clinic Study (MAYO)
• Minnesota Heart Health Program (MHHP)
• Minnesota Heart Survey (MHS)
• Stratis Health Acute MI Validation (STRATIS)